The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Principles of bioinorganic chemistry
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4515 · Cited by 1,534
An Improved Bacterial Test System for the Detection and Classification of Mutagens and Carcinogens
Ames, B. N., Lee, F. D., & Durston, W. E. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.782 · Cited by 1,532
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Principles of bioinorganic chemistry
Chayen, J. (1995) · Cell Biochemistry and Function · doi:10.1002/cbf.290130214 · Cited by 1,055
Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927
The Copper Chaperone for Superoxide Dismutase
Culotta, V. C., Klomp, L. W. J., Strain, J., Casareno, R. L. B., Krems, B., & Gitlin, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23469 · Cited by 850
Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?
Reedijk, J. (1999) · Chemical Reviews · doi:10.1021/cr980422f · Cited by 771
Metal ion chaperone function of the soluble Cu(I) receptor Atx1.
Pufahl, R. A., Singer, C. P., Peariso, K. L., Lin, S.-J., Schmidt, P. J., Fahrni, C. J., Culotta, V. C., Penner-Hahn, J. E., & O'Halloran, T. V. (1997) · Science · doi:10.1126/science.278.5339.853 · Cited by 691
The Nucleobase‐Cation‐Symport‐1 Family of Membrane Transport Proteins
Weyand, S., Ma, P., Saidijam, M., Baldwin, J., Beckstein, O., Jackson, S., Suzuki, S., Patching, S. G., Shimamura, T., Sansom, M. S., et al. (2004) · Handbook of Metalloproteins · doi:10.1002/0470028637.met268 · Cited by 619
New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA
Reedijk, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737293100 · Cited by 617
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Overexpression of Metallothionein Confers Resistance to Anticancer Drugs
Kelley, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H., & Lazo, J. S. (1988) · Science · doi:10.1126/science.3175622 · Cited by 601
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins
Ohndorf, U.-M., Rould, M. A., He, Q., Pabo, C. O., & Lippard, S. J. (1999) · Nature · doi:10.1038/21460 · Cited by 565
The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins
Orphanides, G., Wu, W.-H., Lane, W. S., Hampsey, M., & Reinberg, D. (1999) · Nature · doi:10.1038/22350 · Cited by 554
Medicinal Inorganic Chemistry: Introduction
Orvig, C., & Abrams, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980419w · Cited by 532
The successful regression of large solid sarcoma 180 tumors by platinum compounds.
Rosenberg, B., & Vancamp, L. (1970) · PubMed · Cited by 507
Characterization of , a Yeast Gene Involved in Copper Metabolism and Assembly of Cytochrome Oxidase
Glerum, D. M., Shtanko, A., & Tzagoloff, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14504 · Cited by 497
Specific Binding of Chromosomal Protein HMG1 to DNA Damaged by the Anticancer Drug Cisplatin
Pil, P. M., & Lippard, S. J. (1992) · Science · doi:10.1126/science.1566071 · Cited by 496
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
Hall, M. D., Okabe, M., Shen, D.-W., Liang, X.-J., & Gottesman, M. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.080907.180426 · Cited by 474
Beitrag zur Konstitution anorganischer Verbindungen
Werner, A. (1893) · Zeitschrift für anorganische Chemie · doi:10.1002/zaac.18930030136 · Cited by 474
Structural features of the HMG chromosomal proteins and their genes
Bustin, M., A. Lehn, D., & Landsman, D. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90092-g · Cited by 469
Yuan, D. S., Stearman, R., Dancis, A., Dunn, T., Beeler, T., & Klausner, R. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2632 · Cited by 436
Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity
Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J. W., Chen, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0769 · Cited by 431
Rosenberg, B., Van Camp, L., Grimley, E. B., & Thomson, A. J. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96186-7 · Cited by 420
Houghton, A. N., & Polsky, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00161-7 · Cited by 414
Puig, S., Lee, J., Lau, M., & Thiele, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202547200 · Cited by 396
Recognition of cisplatin adducts by cellular proteins
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00142-7 · Cited by 349
Mann, S. C., Andrews, P. A., & Howell, S. B. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684878 · Cited by 349
Developing new metal-based therapeutics: challenges and opportunities
Hambley, T. W. (2007) · Dalton Transactions · doi:10.1039/b706075k · Cited by 337
Ang, W. H., Khalaila, I., Allardyce, C. S., Juillerat-Jeanneret, L., & Dyson, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0432618 · Cited by 314
A potent cytotoxic photoactivated platinum complex
Mackay, F. S., Woods, J. A., Heringová, P., Kašpárková, J., Pizarro, A. M., Moggach, S. A., Parsons, S., Brabec, V., & Sadler, P. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707742105 · Cited by 303
Metal complexes in medicinal chemistry: new vistas and challenges in drug design
Thompson, K. H., & Orvig, C. (2006) · Dalton Trans. · doi:10.1039/b513476e · Cited by 298
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
Zutphen, S. V., & Reedijk, J. (2005) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2005.03.005 · Cited by 295
Katano, K., Kondo, A., Safaei, R., Holzer, A. K., Samimi, G., Mishima, M., Kuo, Y., Rochdi, M., & Howell, S. B. (2002) · PubMed · Cited by 291
Dresser, M. J., Leabman, M. K., & Giacomini, K. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<397::aid-jps1000>3.0.co;2-d · Cited by 290
The Copper Chaperone CCS Directly Interacts with Copper/Zinc Superoxide Dismutase
Casareno, R. L. B., Waggoner, D., & Gitlin, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23625 · Cited by 270
Fichtinger-Schepman, A. M., van Oosterom, A. T., Lohman, P. H. M., & Berends, F. (2026) · PubMed · doi:10.82135/tno-230308 · Cited by 264
(2004) · Wiley eBooks · doi:10.1002/0470028637 · Cited by 264
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)
Müller, J., Lips, K. S., Metzner, L., Neubert, R. H. H., Koepsell, H., & Brandsch, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.011 · Cited by 262
Song, I.-S., Savaraj, N., Siddik, Z. H., Liu, P., Wei, Y., Wu, C. J., & Kuo, M. T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1543.3.12 · Cited by 259
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs
Safaei, R., & Howell, S. B. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.007 · Cited by 254
Holzer, A. K., Samimi, G., Katano, K., Naerdemann, W., Lin, X., Safaei, R., & Howell, S. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001198 · Cited by 245
Assembly of Cytochrome c Oxidase within the Mitochondrion
Carr, H. S., & Winge, D. R. (2003) · Accounts of Chemical Research · doi:10.1021/ar0200807 · Cited by 239
Lovejoy, K. S., Todd, R. C., Zhang, S., McCormick, M. S., D'Aquino, J. A., Reardon, J. T., Sancar, A., Giacomini, K. M., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803441105 · Cited by 238
The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1154 · Cited by 232
DNA Modifications by antitumor platinum and ruthenium compounds: Their recognition and repair
(2002) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(02)71040-4 · Cited by 230
Biomedical uses and applications of inorganic chemistry. An overview
Farrell, N. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00100-5 · Cited by 227
Pinto, A. L., & Lippard, S. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.14.4616 · Cited by 219
Reed, E., Ozols, R. F., Tarone, R., Yuspa, S. H., & Poirier, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5024 · Cited by 217
Platinum-Induced Filamentous Growth in Escherichia coli
Rosenberg, B., Renshaw, E., Vancamp, L., Hartwick, J., & Drobnik, J. (1967) · Journal of Bacteriology · doi:10.1128/jb.93.2.716-721.1967 · Cited by 212
Ise, T., Nagatani, G., Imamura, T., Kato, K., Takano, H., Nomoto, M., Izumi, H., Ohmori, H., Okamoto, T., Ohga, T., et al. (1999) · PubMed · Cited by 210
Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease
Barnham, K. J., Kenche, V. B., Ciccotosto, G. D., Smith, D. P., Tew, D. J., Liu, X., Perez, K., Cranston, G. A., Johanssen, T. J., Volitakis, I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800712105 · Cited by 209
Spingler, B., Whittington, D. A., & Lippard, S. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010790t · Cited by 207
Sternberg, C. N., Whelan, P., Hetherington, J., Paluchowska, B., Slee, P. H. T. J., Vekemans, K., van Erps, P., Theodore, C., Koriakine, O., Oliver, T., et al. (2005) · Oncology · doi:10.1159/000084201 · Cited by 206
Bypass of DNA Lesions Generated During Anticancer Treatment with Cisplatin by DNA Polymerase η
Alt, A., Lammens, K., Chiocchini, C., Lammens, A., Pieck, J. C., Kuch, D., Hopfner, K.-P., & Carell, T. (2007) · Science · doi:10.1126/science.1148242 · Cited by 203
Trans-Platinum Complexes in Cancer Therapy
Coluccia, M., & Natile, G. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007779314080 · Cited by 202
Self-citationCisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP
Vichi, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7444 · Cited by 172
Mechanism of transcriptional stalling at cisplatin-damaged DNA
Damsma, G. E., Alt, A., Brueckner, F., Carell, T., & Cramer, P. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1314 · Cited by 171
Ac, P., van Dijk, M., & Lohman, P. H. M. (1984) · PubMed · Cited by 170
Ueber die Einwirkung des Ammoniaks auf Platinchlorür
Peyrone, M. (1844) · Justus Liebigs Annalen der Chemie · doi:10.1002/jlac.18440510102 · Cited by 168
Role of copper transporters in the uptake and efflux of platinum containing drugs
Safaei, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.046 · Cited by 160
Jiang, J., Nadas, I. A., Kim, M. A., & Franz, K. J. (2005) · Inorganic Chemistry · doi:10.1021/ic051180m · Cited by 150
Safaei, R., Katano, K., Larson, B. J., Samimi, G., Holzer, A. K., Naerdemann, W., Tomioka, M., Goodman, M., & Howell, S. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.756.11.2 · Cited by 141
The Internalization and Degradation of Human Copper Transporter 1 following Cisplatin Exposure
Holzer, A. K., & Howell, S. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1710 · Cited by 140
Nature of Full-Length HMGB1 Binding to Cisplatin-Modified DNA
Jung, Y., & Lippard, S. J. (2003) · Biochemistry · doi:10.1021/bi026972w · Cited by 120
Zlatanova, J. S., Yaneva, J. N., & Leuba, S. H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.791 · Cited by 99
Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine
Binks, S. P., & Dobrota, M. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90400-f · Cited by 91
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines
Chauhan, S. S., Liang, X., Su, A. W., Panandiker, A. S. P., Shen, D. W., Hanover, J. A., & Gottesman, M. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600861 · Cited by 90
Satraplatin: an orally available platinum analog for the treatment of cancer
Choy, H. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.7.973 · Cited by 88
Knipp, M., Karotki, A. V., Chesnov, S., Natile, G., Sadler, P. J., Brabec, V., & Vašák, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070271l · Cited by 85
Self-citationKašpárková, J., Vojtı́šková, M., Natile, G., & Brabec, V. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200701352 · Cited by 84
Self-citationPerspectives in Inorganic Structural Genomics: A Trafficking Route for Copper
Arnesano, F., Banci, L., Bertini, I., & Ciofi‐Baffoni, S. (2004) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200300841 · Cited by 81
Self-citationWei, M., Cohen, S. M., Silverman, A. P., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106374200 · Cited by 79
Dunham, S. U., & Lippard, S. J. (1997) · Biochemistry · doi:10.1021/bi9709452 · Cited by 77
Cytoplasmic initiation of cisplatin cytotoxicity
Yu, F., Megyesi, J. K., & Price, P. M. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00593.2007 · Cited by 77
Distribution and function of classes of ATPases along the nephron
Katz, A. I. (1986) · Kidney International · doi:10.1038/ki.1986.4 · Cited by 75
Conformation of DNA GG Intrastrand Cross-Link of Antitumor Oxaliplatin and Its Enantiomeric Analog
Malina, J., Nováková, O., Vojtı́šková, M., Natile, G., & Brabec, V. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.116996 · Cited by 70
Self-citationAida, T., Takebayashi, Y., Shimizu, T., Okamura, C., Higasimoto, M., Kanzaki, A., Nakayama, K., Terada, K., Sugiyama, T., Miyazaki, K., et al. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.042 · Cited by 68
NMR Solution Structure of an Oxaliplatin 1,2-d(GG) Intrastrand Cross-link in a DNA Dodecamer Duplex
Wu, Y., Pradhan, P., Havener, J. M., Boysen, G., Swenberg, J. A., Campbell, S. L., & Chaney, S. G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.066 · Cited by 66
Decreased cisplatin uptake by resistant L1210 leukemia cells
Hromas, R., North, J. A., & Burns, C. P. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90091-7 · Cited by 65
Natile, G., & Marzilli, L. G. (2006) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2005.12.004 · Cited by 65
Self-citation"Platinum on the road": Interactions of antitumoral cisplatin with proteins
Arnesano, F., & Natile, G. (2008) · Pure and Applied Chemistry · doi:10.1351/pac200880122715 · Cited by 63
Self-citationMalina, J., Kašpárková, J., Natile, G., & Brabec, V. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00134-5 · Cited by 61
Self-citationLiang, X., Shen, D., Chen, K. G., Wincovitch, S., Garfield, S. H., & Gottesman, M. M. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20253 · Cited by 57
Cheng, P., Liu, S., Hsu, C., et al. (2005) · Hearing Research · doi:10.1016/j.heares.2005.03.008 · Cited by 56
Platinated Copper(3‐Clip‐Phen) Complexes as Effective DNA‐Cleaving and Cytotoxic Agents
Özalp‐Yaman, Ş., de Hoog, P., Amadei, G. A., Pitié, M., Gámez, P., Dewelle, J., Mijatovic, T., Meunier, B., Robert Kiss, A., & Reedijk, J. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200702021 · Cited by 46
Coin, F., Frit, P., Viollet, B., Salles, B., & Egly, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3907 · Cited by 45
Beale, P. J., Judson, I. R., O’Donnell, A. E., Trigo, J. M., Rees, C., Raynaud, F. I., Turner, A., Simmons, L., & Etterley, L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600854 · Cited by 43
Recognition of DNA Interstrand Cross-link of Antitumor Cisplatin by HMGB1 Protein
Kašpárková, J., Delalande, O., Štros, M., Elizondo-Riojas, M.-Á., Vojtíšková, M., Kozelka, J., & Brabec, V. (2003) · Biochemistry · doi:10.1021/bi026695t · Cited by 39
Bartnikas, T. B., & Gitlin, J. D. (2001) · Nature Structural Biology · doi:10.1038/nsb0901-733 · Cited by 35
Delalande, O., Malina, J., Brabec, V., & Kozelka, J. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.054650 · Cited by 27
Cisplatin-induced cytoxicity: is the nucleus relevant?
Sheikh‐Hamad, D. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90293.2008 · Cited by 18
Cited by
Advances in Copper Complexes as Anticancer Agents
Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2014) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,790
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Wilson, J. J., & Lippard, S. J. (2014) · Chemical Reviews · doi:10.1021/cr4004314 · Cited by 630
Encyclopedia of Metalloproteins
(2013) · Springer eBooks · doi:10.1007/978-1-4614-1533-6 · Cited by 531
When self-assembly meets biology: luminescent platinum complexes for imaging applications
Mauro, M., Aliprandi, A., Septiadi, D., Kehr, N. S., & De Cola, L. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60453e · Cited by 385
The path for metal complexes to a DNA target
Komor, A. C., & Barton, J. K. (2013) · Chemical Communications · doi:10.1039/c3cc00177f · Cited by 384
Metadata
- Authors
- Arnesano, F., & Natile, G.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 253
- Issue
- 15-16
- Pages
- 2070-2081
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2114611012
- Cited by
- 282
- References
- 101
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.